Integrated Diagnostics Holdings PLC (LSE:IDHC) shares fell 9% after the consumer healthcare group reported a 31% fall in revenues and a 54% tumble in underlying profits with its prelims.
The group, which has operations in Egypt, Jordan, Nigeria and Sudan, said the challenging economic conditions seen in 2022 were unlikely to improve in the near term.
The stock, off 62% in the past year, fell 0.04p to 0.44p on Thursday.